Phase II Study of Concurrent Pemetrexed and Radiation for Stage III Non-Small Cell Lung Cancer

For full description, see www.clinicaltrials.gov.

Abstracts/Posters/Presentations:

• J. L. Feliciano, N. H. Hanna, A. Fakiris, M. Yu, W. M. Dugan, J. McClean, J. A. Bufill, S. Bhatia, J. D. Patel. A phase II study of concurrent pemetrexed and radiation for poor risk stage III non-small cell lung cancer (NSCLC): Hoosier Oncology Group LUN08-129. Accepted to the publication-only session at the 2011 ASCO Annual Meeting, June 4-8 2011, Chicago, IL. See abstract.